Sarcopenia in patients with liver cirrhosis (LC) has been attracting much attention these
days because of the close linkage to adverse outcomes. LC can be related to secondary …

Sarcopenia is the loss of muscle mass and function, affecting up to 70% of patients with
advanced liver disease. Liver cirrhosis is characterized by an altered glucose metabolism …

Background Sarcopenia in liver cirrhosis is associated with low quality of life and high
mortality risk. The pathogenesis has yet to be fully understood. We hypothesized that gut …

Background & Aims Sarcopenia and gut dysbiosis are common in individuals with cirrhosis.
However, the association between sarcopenia and microbial alterations, and the …

Decreased muscle mass and function, also known as sarcopenia, is common in patients
with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this …

Abstract Background & Aim Sarcopenia is frequent in cirrhosis and is associated with
unfavourable outcomes. The role of the gut‐liver‐muscle axis in this setting has been poorly …

Liver cirrhosis is frequently accompanied by disease-related malnutrition (DRM) and
sarcopenia, defined as loss of skeletal muscle mass and function. DRM and sarcopenia …

Aim Sarcopenia is associated with poor health-related quality of life (HRQOL) in the general
population. However, in cirrhotic patients, as the development of sarcopenia is closely …

Sarcopenia is thought to be related to the microbiome, but not enough reports in chronic
liver disease (CLD) patients. In addition to the differences in microbiome, the role of the …

Sarcopenia, a condition of low muscle mass, quality, and strength, is commonly found in
patients with chronic liver disease (CLD) and is associated with adverse clinical outcomes …